Hedge Funds Aren’t Crazy About Cytokinetics, Inc. (CYTK) Anymore

Company Name # of Hedge Funds # of Insiders Buying # of Insiders Selling
ShangPharma Corp (ADR) (NYSE:SHP) 6 0 0
ArQule, Inc. (NASDAQ:ARQL) 13 0 0
OncoGenex Pharmaceuticals Inc (NASDAQ:OGXI) 4 0 0
Enzon Pharmaceuticals, Inc. (NASDAQ:ENZN) 10 0 0
Durata Therapeutics Inc (NASDAQ:DRTX) 5 7 0

With the results exhibited by the aforementioned strategies, retail investors should always monitor hedge fund and insider trading activity, and Cytokinetics, Inc. (NASDAQ:CYTK) applies perfectly to this mantra.

Click here to learn why you should track hedge funds